Accelerate clinical trials in CMT (actcmt) study

Ended Cooperative Agreement Awarded Last action

Award ID
U01NS109403
Recipient
Awarding agency
Obligated
$13,930,383

Award facts

Completion date
Originally
Funding
  • $11,331,466.08 Federal
  • $2,598,917.00 Non-federal
Place of performance
New York, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$8,797 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,059,590 $0
Amendment $1,059,590 $0
Amendment $125,863 $0
Amendment $125,863 $125,863
Amendment $125,863 $0
Amendment $1,132,758 $0
Amendment $1,132,758 $1,132,758
Amendment $1,132,758 $0
Amendment $1,340,296 $0
Amendment $1,340,296 $1,340,296
Amendment $0 $0
Amendment Accelerate clinical trials in CMT (actcmt) study - charcot marie tooth disease (CMT) is a family of rare inherited peripheral neuropathies. CMT1A accounts for… $0 $0
Amendment $1,343,853 $0
Amendment $0 $0
Amendment $234,459 $0
Original award $1,186,316 $0
Show all 20

Subawards

Subrecipient Amount Awarded
Fondazione Irccs Istituto Neurologico Carlo Besta Accelerate Clinical Trials in CMT (ACTCMT) Study $275,040
University Of Sydney Accelerate Clinical Trials In CMT (ACTCMT) Study $282,288
The Trustees Of The University Of Pennsylvania $518,214
University College London Accelerate Clinical Trials in CMT (ACTCMT) Study $1,061,278

Quick answers

Who received award U01NS109403?

U01NS109403 was awarded to University Of Rochester by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on May 1, 2019.

How much is award U01NS109403 worth?

$13,930,383 has been obligated on U01NS109403: $11,331,466 in federal funding and $2,598,917 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award